Dana-Farber Cancer Institute
banner
danafarber.bsky.social
Dana-Farber Cancer Institute
@danafarber.bsky.social
A leading center for expert, compassionate cancer care and advanced research.
Appts: 877-442-3324 | http://dana-farber.org
A historic moment.

Last week, we announced the largest single gift in our history through a transformational joint commitment from Josh and Anita Bekenstein and the Jonathan and Jeannie Lavine family.
February 11, 2026 at 9:45 PM
We’re proud to announce a new strategic collaboration with OncoClinic to bring advanced and personalized oncology to Saudi Arabia. Learn more: bit.ly/4afscrT
February 9, 2026 at 4:25 PM
Congratulations to Alice Shaw, MD, PhD, Kimberly Stegmaier, MD, and Matthew Vander Heiden, MD, PhD, on being elected as Fellows of the @theaacr.bsky.social Academy Class of 2026. Learn more: bit.ly/45KykqC
February 7, 2026 at 2:00 PM
We are deeply grateful for these two families’ decades-long dedication to our mission.
February 6, 2026 at 5:01 PM
This week, we had the honor celebrating the largest single gift in our history: a transformative joint commitment from the Josh and Anita Bekenstein and Jonathan and Jeannie Lavine families to name and help build our future cancer hospital.
February 6, 2026 at 5:01 PM
We are profoundly grateful to announce the largest single gift in our 78-year history through a new joint commitment from Josh and Anita Bekenstein and the Jonathan Lavine and Jeannie Lavine family.
February 4, 2026 at 5:31 PM
The 2026 Transatlantic Exchange in Oncology Conference, hosted by Dana-Farber and @gustaveroussy.fr, will take place in Boston on March 27. This year’s event, co-chaired by @drchoueiri.bsky.social, MD, will focus on Transatlantic Innovations in Cancer Drug Research.

Register here: bit.ly/4bs5q2n
February 1, 2026 at 2:45 PM
The list is out! More than 145 Dana-Farber affiliated faculty are recognized as 2026 Top Doctors by @bostonmagazine.bsky.social. Congratulations to all!

View the list here: bit.ly/49YcUaW
January 27, 2026 at 2:54 PM
We hope everyone is staying safe and warm this weekend. We will work to accommodate patients who may be delayed or need to reschedule. ❄️
January 25, 2026 at 9:30 PM
Please join us in congratulating Philip J. Kranzusch, PhD, on receiving the 2026 NAS Award in Molecular Biology. Kranzusch’s seminal work has reshaped our understanding of human innate immunity, revealing its evolutionary links to bacterial antiviral defense. Learn more: bit.ly/4roj0sj
January 25, 2026 at 2:00 PM
Lachelle Weeks, MD, PhD, treats patients with acute myeloid leukemia, one of the hardest blood cancers to treat. She believes survival rates can be improved not just with new treatments, but also by finding ways to prevent the disease before it starts.

Learn more: bit.ly/4sDXMb1
January 14, 2026 at 5:05 PM
Goldie Taylor, Senior Vice President, Chief Communications and Marketing Officer, has been named to Ragan’s Top Women in Communications, Class of 2026, recognized in the Healthcare Communicators category. Please join us in congratulating her on this recognition.

View the full list: bit.ly/4b2jyyL
January 1, 2026 at 5:05 PM
How much has cancer care changed in the first quarter of this century? Quite a lot, thanks to cancer research here and around the world. Get the details here: bit.ly/4pJ9Ju9
December 31, 2025 at 1:31 PM
We’re proud to be included in Becker’s Great Hospitals in America list, which recognizes organizations that stand out for exceptional clinical performance, unwavering focus on patient safety, and dedication to innovation, research and education. View the full list here: bit.ly/49nr2Lv
December 27, 2025 at 1:30 PM
Meet Evan Chen, MD, a medical oncologist who treats patients with acute leukemias and myeloid malignancies. Learn more about his clinic research, which focuses on the development of cellular therapies for leukemias and translational studies of leukemia epigenetics: bit.ly/48ZI6rp
December 16, 2025 at 1:00 PM
Congratulations to Robert Soiffer, MD, the 2025 recipient of the Edward J. Benz Award for Advancing the Careers of Dana-Farber Faculty. This annual award recognizes a faculty member who goes above and beyond to advance the careers of fellow faculty.
December 15, 2025 at 2:30 PM
Congratulations to Nolan Priedigkeit, MD, PhD, on receiving the 2025 @sabcs.bsky.social Rising Star Award, which recognizes early career scientists and clinicians conducting impactful research in the field of breast cancer.
December 10, 2025 at 10:30 PM
Improvements in immunotherapy are leading to favorable results and reduced toxicities in treating patients with acute lymphoblastic leukemia. Get up to speed on the latest with Marlise R. Luskin, MD, MSCE: bit.ly/3JhTFQo
December 9, 2025 at 8:00 PM
Johann-Christoph Jann, MD, presents new research on the activation of endogenous retroviral elements that may drive inflammation and cellular transformation in STAG2-mutant myeloid malignancies. @tothovalab.bsky.social #ASH25
December 8, 2025 at 10:04 PM
We’re back today at #ASH25. Follow along here and with @danafarbernews.bsky.social as we learn and explore the latest in blood cancer care and research or join us at our upcoming discussions and poster presentations: bit.ly/3LYDHeL
December 8, 2025 at 2:23 PM
December 7, 2025 at 11:54 PM
December 7, 2025 at 11:54 PM
The second day of poster presentations at #ASH25 featured research ranging from venetoclax and pirtobrutinib in relapsed/refractory Waldenström's macroglobulinemia to spatial proteomics of the bone marrow.
December 7, 2025 at 11:53 PM
Andrew Lane, MD, PhD, shares an update on TAG-AZA-VEN for BPDCN.
“These early results point to a safer, more workable option that can keep patients on track, often toward transplant, while addressing co-existing disease.” #ASH25
December 7, 2025 at 10:31 PM
Austin Kim, MD, presents results from the phase 1/2 MAVO study evaluating acalabrutinib + venetoclax + obinutuzumab in patients with relapsed/refractory and previously untreated mantle cell lymphoma.
#ASH25
December 7, 2025 at 10:18 PM